| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 782 | 623 | 21 |
| Full Text Views | 10 | 1 | 1 |
| PDF Downloads | 6 | 0 | 0 |
Chemosuppressive Field Trials in Thailand
III. The Suppression of Plasmodium falciparum and Plasmodium vivax Parasitemias by a Sulfadoxine-Pyrimethamine Combination
Eliot J. Pearlman
Eliot J. Pearlman
United States Army Medical Component, Southeast Asia Treaty Organization, APO San Francisco 96346
Search for other papers by Eliot J. Pearlman in
Current site
Google Scholar
PubMed
Search for other papers by Eliot J. Pearlman in
Current site
Google Scholar
PubMed
Richard M. Lampe
Richard M. Lampe
United States Army Medical Component, Southeast Asia Treaty Organization, APO San Francisco 96346
Search for other papers by Richard M. Lampe in
Current site
Google Scholar
PubMed
Search for other papers by Richard M. Lampe in
Current site
Google Scholar
PubMed
Withoon Thiemanun
Withoon Thiemanun
United States Army Medical Component, Southeast Asia Treaty Organization, APO San Francisco 96346
Search for other papers by Withoon Thiemanun in
Current site
Google Scholar
PubMed
Search for other papers by Withoon Thiemanun in
Current site
Google Scholar
PubMed
Robert S. Kennedy
Robert S. Kennedy
United States Army Medical Component, Southeast Asia Treaty Organization, APO San Francisco 96346
Search for other papers by Robert S. Kennedy in
Current site
Google Scholar
PubMed
Search for other papers by Robert S. Kennedy in
Current site
Google Scholar
PubMed
A chemosuppressive field trial in an area of Thailand with known chloroquineresistant falciparum malaria was undertaken to test the efficacy of the preparation sulfadoxine (S)-pyrimethamine (Py) in suppressing falciparum and vivax parasitemias. Seven hundred and forty-seven Thai villagers were randomly assigned to one of five study groups: sulfadoxine (1,000 mg)-pyrimethamine (50 mg) every 2 weeks [S-Py (high dose)]; sulfadoxine (500 mg)-pyrimethamine (25 mg) every 2 weeks [S-Py (low dose)]; diformyldapsone (400 mg)-pyrimethamine (25 mg) weekly [DFD-Py (high dose)]; diformyldapsone (200 mg)-pyrimethamine (12.5 mg) weekly [DFD-Py (low dose)]; and placebo. Six hundred and eight-eight study subjects (92%) completed the 26-week trial. Sulfadoxine (1,000 mg)-pyrimethamine (50 mg) given every 2 weeks was shown to be an effective chemosuppressive against both falciparum and vivax parasitemias, causing an eight-fold reduction in falciparum parasitemias, and an approximately three-fold reduction in vivax parasitemias. While the low dose S-Py group and the two DFD-Py groups were less effective than the high dose S-Py group in suppressing falciparum parasitemias, the high dose DFD-Py combination was as effective as the high dose S-Py combination in suppressing vivax parasitemias. There was no evidence of drug reactions. A discernible decrease in the leukocyte count was noted over a 6-month period in the high dose S-Py group.
Author Notes
Present address: Division Surgeon, 3rd Armored Division, APO New York 09039.
Present address: Department of Pediatrics, William Beaumont General Hospital, El Paso, Texas 79920.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 782 | 623 | 21 |
| Full Text Views | 10 | 1 | 1 |
| PDF Downloads | 6 | 0 | 0 |